Optimal Timing of a Tailored Physical Activity Program During Chemotherapeutic Cancer Treatment to Reduce Long-term Cardiovascular Morbidity
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Difference in VO2 max between the groups after completion of the PA program.
The aim of this study is investigate whether a tailored PA program that starts early (during curative chemotherapy with cardiovascular toxic potential) is superior in terms of reducing long-term cancer-treatment-related metabolic syndrome and cardiovascular morbidity to a program that starts late (after completion of chemotherapy).
1 year
No
Annemiek Walenkamp, PhD
Principal Investigator
University Medical Centre Groningen
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
2012-0010
NCT01642680
January 2013
September 2016
Name | Location |
---|